Posts Tagged ‘抗癌藥物’

Home抗癌藥物

Polaris Pharmaceuticals focuses on developing metabolic therapy drugs for cancer to alleviate patient discomfort and reduce side effects. In 2022, the company achieved a milestone by completing its clinical trial for lung mesothelioma, and several of its cancer drugs have entered Phase III clinical trials, moving towards obtaining drug approvals in various countries. In addition, the company undertakes contract development and manufacturing organization (CDMO) services for biopharmaceuticals, and its R&D investment has been increasing year by year. In the future, it will implement an automated management system to monitor energy consumption.

Sinochem Holdings has long encouraged Taiwanese people to engage in biotechnology and pharmaceutical research and new drug development. Through new drug licensing, it not only expands the application areas but also promotes public health. Regarding process wastewater management, Sinochem Holdings complies with regulations and minimizes ecological risks. It also operates mobile health vehicles to rural areas to care for the elderly, demonstrating the company's commitment to sustainability. In 2023, Sinochem Pharmaceuticals achieved significant results in the pharmaceutical field, independently developing nine new products covering a variety of drugs.